RAYOS (prednisone) 5mg delayed-release tablets Horizon Pharma announced that the FDA has approved Rayos (prednisone) delayed-release tablets for the treatment of rheumatoid arthritis (RA), polymyalgia ...
New research found that people with lupus whose disease is in remission for at least one year, and who are at high risk of relapse, benefit from a continued low dose (5mg.) of Prednisone versus ...
The FDA approval was supported by results from the Phase 3 multinational, multicenter, randomized, double-blind, placebo-controlled LATITUDE trial (N=1,199) which evaluated Zytiga 1000mg once daily in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback